Compare NKTX & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | FONR |
|---|---|---|
| Founded | 2015 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.8M | 116.9M |
| IPO Year | 2020 | 1987 |
| Metric | NKTX | FONR |
|---|---|---|
| Price | $2.09 | $18.56 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $13.25 | N/A |
| AVG Volume (30 Days) | ★ 708.2K | 128.9K |
| Earning Date | 11-10-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.08 |
| Revenue | N/A | ★ $105,434,318.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.10 |
| Revenue Growth | N/A | ★ 3.36 |
| 52 Week Low | $1.31 | $12.00 |
| 52 Week High | $2.74 | $18.86 |
| Indicator | NKTX | FONR |
|---|---|---|
| Relative Strength Index (RSI) | 69.68 | 80.85 |
| Support Level | $1.79 | $18.50 |
| Resistance Level | $2.22 | $18.86 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | 0.04 | 0.31 |
| Stochastic Oscillator | 75.73 | 93.27 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.